The molecular etiology of breast cancer: Evidence from biomarkers of risk

International Journal of Cancer

Volumn 122, Issue 9, 2008, Pages 1949-1957

  Gaikwad, Nilesh W ^a   Yang, Li ^a   Muti, Paola ^b   Meza, Jane L ^a   Pruthi, Sandhya ^c   Ingle, James N ^c   Rogan, Eleanor G ^a   Cavalieri, Ercole L ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c MAYO CLINIC   (United States)

Author keywords

Balance in estrogen metabolism; Breast cancer risk; Depurinating estrogen dna adducts; Estrogen biomarkers

Indexed keywords

ESTROGEN DERIVATIVE; TUMOR MARKER; CONJUGATED ESTROGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CONJUGATE; CONTROL GROUP; CONTROLLED STUDY; DNA ADDUCT; DNA PURIFICATION; FEMALE; HEALTH STATUS; HIGH RISK POPULATION; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; METABOLITE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; TANDEM MASS SPECTROMETRY; URINALYSIS; ANALYSIS OF VARIANCE; BREAST TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; ITALY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; UNITED STATES; URINE;

ADULT; AGED; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CHROMATOGRAPHY, LIQUID; CROSS-SECTIONAL STUDIES; DNA ADDUCTS; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; ITALY; LINEAR MODELS; MIDDLE AGED; MODELS, STATISTICAL; REFERENCE VALUES; RISK ASSESSMENT; RISK FACTORS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 40749161927     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23329     Document Type: Article

References (29)

1. Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, Muti P, Rogan E, Russo J, Santen R, Sutter T. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 2006;1766:63-78.
2. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997;278:1073-7.
3. Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
4. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005;97:755-65.
5. Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK, Ramanathan R, Cerny RL, et al. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 1997;94:10937-42.
6. Li KM, Todorovic R, Devanesan P, Higginbotham S, Kofeler H, Ramanathan R, Gross ML, Rogan EG, Cavalieri EL. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 2004;25:289-97.
7. Zahid M, Kohli E, Saeed M, Rogan E, Cavalieri E. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity. Chem Res Toxicol 2006;19:164-72.
8. Saeed M, Rogan E, Fernandez SV, Sheriff F, Russo J, Cavalieri E. Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol. Int J Cancer 2007;120:1821-4.
9. Markushin Y, Zhong W, Cavalieri EL, Rogan EG, Small GJ, Yeung ES, Jankowiak R. Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract. Chem Res Toxicol 2003;16:1107-17.
10. Chakravarti D, Mailander PC, Li KM, Higginbotham S, Zhang HL, Gross ML, Meza JL, Cavalieri EL, Rogan EG. Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene. Oncogene 2001;20:7945-53.
11. Mailander PC, Meza JL, Higginbotham S, Chakravarti D. Induction of A.T to G.C mutations by erroneous repair of depurinated DNA following estrogen treatment of the mammary gland of ACI rats. J Steroid Biochem Mol Biol 2006;101:204-15.
12. Zhao Z, Kosinska W, Khmelnitsky M, Cavalieri EL, Rogan EG, Chakravarti D, Sacks PG, Guttenplan JB. Mutagenic activity of 4-hydroxyestradiol, but not 2-hydroxyestradiol, in BB rat2 embryonic cells, and the mutational spectrum of 4-hydroxyestradiol. Chem Res Toxicol 2006;19:475-9.
13. Fernandez SV, Russo IH, Russo J. Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. Int J Cancer 2006;118:1862-8.
14. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR. 17 β-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 1996;93:9776-81.
15. Mannisto PT, Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 1999;51:593-628.
16. Cavalieri EL, Kumar S, Todorovic R, Higginbotham S, Badawi AF, Rogan EG. Imbalance of estrogen homeostasis in kidney and liver of hamsters treated with estradiol: implications for estrogen-induced initiation of renal tumors. Chem Res Toxicol 2001;14:1041-50.
17. Gaikwad NW, Rogan EG, Cavalieri EL. Evidence by ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones. Free Radic Biol Med 2007;43:1289-98.
18. Russo J, Hasan Lareef M, Balogh G, Guo S, Russo IH. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol 2003;87:1-25.
19. Lareef MH, Garber J, Russo PA, Russo IH, Heulings R, Russo J. The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-β-estradiol and 4-OH estradiol in human breast epithelial cells. Int J Oncol 2005;26:423-9.
20. Russo J, Fernandez SV, Russo PA, Fernbaugh R, Sheriff FS, Lareef HM, Garber J, Russo IH. 17-β-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J 2006;20:1622-34.
21. Liehr JG, Fang WF, Sirbasku DA, Ari-Ulubelen A. Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem 1986;24:353-6.
22. Li JJ, Li SA. Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed Proc 1987;46:1858-63.
23. Newbold RR, Liehr JG. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 2000;60:235-7.
24. Yue W, Santen RJ, Wang JP, Li Y, Verderame MF, Bocchinfuso WP, Korach KS, Devanesan P, Todorovic R, Rogan EG, Cavalieri EL. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol 2003;86:477-86.
25. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86.
26. Saeed M, Zahid M, Rogan E, Cavalieri E. Synthesis of the catechols of natural and synthetic estrogens by using 2-iodoxybenzoic acid (IBX) as the oxidizing agent. Steroids 2005;70:173-8.
27. Cao K, Stack DE, Ramanathan R, Gross ML, Rogan EG, Cavalieri EL. Synthesis and structure elucidation of estrogen quinones conjugated with cysteine, N-acetylcysteine, and glutathione. Chem Res Toxicol 1998;11:909-16.
28. Stack DE, Byun J, Gross ML, Rogan EG, Cavalieri EL. Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem Res Toxicol 1996;9:851-9.
29. Boyland E, Chasseaud LF. The role of glutathione and glutathione S- transferases in mercapturic acid biosynthesis. Adv Enzymol Relat Areas Mol Biol 1969;32:173-219.